Don't want to trade it yourself?
Our desk runs DEX portfolios on profit share.
35%
Share
$2.5K
Minimum
Nasdaq-listed HYPE accumulation firm Hyperliquid Strategy said it was not the buyer in Hyperliquid Labs’ $320 million over-the-counter sale of HYPE, according to Zoomer News. CEO David Shammas said on X the company was not involved as the purchaser in the transaction.